Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth R Howell

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Frontiers in Aging Neuroscience|February 24, 2022
Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2<sup>*</sup>R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|October 28, 2021
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 5, 2022
Perspectives on Cognitive Phenotypes and Models of Vascular DiseaseSelen C Muratoglu, Marc F Charette, Zorina S Galis, et al.
Science (New York, N.Y.)|March 26, 2011
Mutations in the RNA granule component TDRD7 cause cataract and glaucomaSalil A Lachke, Fowzan S Alkuraya, Stephen C Kneeland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2024
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau PathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Aging Neuroscience|February 24, 2022
Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2<sup>*</sup>R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|October 28, 2021
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 5, 2022
Perspectives on Cognitive Phenotypes and Models of Vascular DiseaseSelen C Muratoglu, Marc F Charette, Zorina S Galis, et al.
Science (New York, N.Y.)|March 26, 2011
Mutations in the RNA granule component TDRD7 cause cataract and glaucomaSalil A Lachke, Fowzan S Alkuraya, Stephen C Kneeland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2024
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau PathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Pageof 13